Professional Documents
Culture Documents
Aim: To explore the feasibility of human placenta extracellular matrix (HPECM) hydrogel in restoring the
hair-inductive capacity of high-passaged (P8) dermal papilla cells (DPCs) for hair follicle regeneration.
Materials & methods: HPECM hydrogel was prepared following decellularization and enzymatic solubi-
lization treatment. DPCs isolated from human scalp were cultured in 2D and 3D environments. The hair-
inductive ability of DPCs was assessed by quantitative RT-PCR, immunofluorescence staining, immunoblot-
ting and patch assay. Results: DPCs (P8) formed spheres when cultured on the HPECM hydrogel. The ex-
pression levels of Versican, ALP, and β-catenin were restored in the DP spheres. HPECM hydrogel-cultured
DP spheres co-grafted with newborn mouse epidermal cells regenerated new hair follicle. Conclusion:
HPECM hydrogel successfully restores the hair-inductive capacity of high-passaged DPCs.
First draft submitted: 2 September 2018; Accepted for publication: 10 July 2019; Published online:
1 August 2019
Keywords: 3D culture • decellularization • dermal papilla cell • extracellular matrix • hair follicle regeneration • hair
loss • human placenta • hydrogel • thermosensitive • tissue-engineering
Hair has a cosmetic function, affecting an individual’s physical appearance, and consequently hair loss caused by
aging, disease, trauma or medication is one of the most distressing disorders for both men and women [1,2]. Current
therapeutic options for hair loss include either drugs or autologous hair follicle (HF) transplantation [3]. However,
the effectiveness of both treatments is limited because of their inability to regenerate new HFs [4–6]. With recent
progress in regenerative medicine and tissue engineering, rearranging follicle cells in their biomimetic environment
to reconstruct HFs is showing promise [7,8].
HF reconstruction involves complex interactions between epithelial cells and dermal cells [9]. Dermal papilla cells
(DPCs) are believed to play a key role in HF morphogenesis and cycling and have become an essential cell source in
HF reconstruction [10]. However, DPCs tend to lose their hair-inductive capacity during subculture when cells are
cultured in traditional 2D culture conditions [11]. Physiologically, almost all tissue cells reside in extracellular matrix
(ECM). The ECM provides specific physical and chemical cues that regulate cell behaviors such as cell survival,
proliferation, migration and differentiation [12]. Lack of a suitable microenvironment to mimic the 3D structure
and composition of the natural ECM causes DPCs to gradually lose their hair-inductive capacity in 2D culture [13].
Previous studies have shown that a synergistic effect between cells and ECM can be created by constructing a
complex 3D niche including physical–chemical stimulation and soluble signals [14]. Some matrix materials such as
hyaluronic acid [15], collagen [16] and basement membrane matrix [17] have been used to restore the hair-inductive
ability of DPCs by formation of spheroids in 3D culture. However, these methods have limitations, such as the
variable size of spheroids and difficulty of controlling the system, meaning that long-term cultivation of DPCs is
not viable. Additionally, since basement membrane matrix is a heterogeneous tumor cell-derived protein, its safety
in clinical use is unclear.
Human placentas are commonly discarded and can be harvested without harm to the donor. The matrix
components of human placenta extracellular matrix (HPECM) are collagens, laminin, fibronectin, glycoproteins
10.2217/rme-2018-0112
C 2019 Future Medicine Ltd Regen. Med. (Epub ahead of print) ISSN 1746-0751
Research Article Zhang, Xiao, Shu, Liu, Miao & Hu
and growth factors [18]. HPECM hydrogel can support the culture of cardiomyocytes and stem cells as well as blood
vessel assembly from endothelial cells [19]. In addition, several growth factors found in the placenta are involved
in promoting the wound healing process and hair growth [20,21]. Consequently, the compositional and biological
properties of HPECM hydrogel have the potential to provide a highly favorable environment for 3D culture of
DPCs. In this study, we used an HPECM hydrogel to create a suitable microenvironment for DPCs in vivo and
to explore its potential for restoring the hair-inductive capacity of high-passaged DPCs for HF regeneration. We
expected that HPECM hydrogel could provide not only structural support for DPCs but also mechanical and
chemical cues to induce hair follicle formation.
Decellularization assessment
Hematoxylin–eosin (H&E) staining was used to evaluate the effectiveness of the decellularization process. Native
and decellularized human placentas were fixed in 10% formaldehyde at room temperature for 24 h then paraffin
sections were prepared and stained with H&E.
Immunofluorescent staining
Immunofluorescent staining was performed according to established methods. Briefly, samples including 2D-P8-
DPCs, 2D-P2-DPCs and HPECM hydrogel-P8–DP spheres were collected, washed and fixed in 4% paraformalde-
hyde (Gibco). The following rabbit monoclonal primary antibodies were used: ALP (1:100; Abcam, Cambridge,
UK); β-catenin and Versican (1:200; Abcam). After incubation with primary antibodies overnight at 4◦ C, sam-
ples were incubated with the corresponding goat antirabbit IgG antibodies (1:200; Abcam) and DAPI (1:500;
Sigma-Aldrich) for 1 h at room temperature. Images were captured using a fluorescence microscope (IX81 FL,
Olympus).
Western blotting
Total protein was extracted using RIPA lysis buffer (Gibco) according to the manufacturer’s instructions. The
extracted protein (30 μg) from each sample was subjected to sodium dodecyl sulfate/polyacrylamide gel elec-
trophoresis and transferred to a polyvinylidene difluoride membrane. Primary antibodies were: ALP (1:10,000),
β-catenin (1:5,000), versican (1:5,000) and GAPDH (1:1,000) monoclonal antibody (all from Santa Cruz Biotech-
nology, Inc., CA, USA). Immune complexes were detected using an enhanced chemiluminescence kit (Santa Cruz
Biotechnology, Inc.) and further quantified by the analyst/PC densitometry software (Bio-Rad Laboratories, CA,
USA).
Statistical analysis
Data are expressed as mean ± standard deviation. One-way analysis of variance was performed for comparison
between different groups using SPSS17.0 software (IBM, NY, USA). Differences in p-values of less than 0.05 were
regarded as statistically significant.
Results
Characterization of HPECM hydrogel
Human placentas were washed several times to remove blood components (Figure 1A). Numerous cell nuclei were
visible in the tissue before decellularization (Figure 1B). After decellularization treatment (Figure 1C), few nuclei
were visible (Figure 1D). The absence of nuclei demonstrated the complete decellularization of the tissue compared
with native human placenta. Pepsin-solubilized HPECM remained as a viscous liquid at room temperature, but
gelation occurred in <30 min when incubated at 37◦ C (Figure 1E). These thermosensitive HPECM hydrogels
displayed sol–gel properties similar to those of commercial purified collagen gels. The mean concentrations of
PDGF and FGF in supernatants of HPECM hydrogels were 0.39 ± 0.06 and 1.27 ± 0.08 ng/ml, respectively.
12 h 24 h 72 h
Figure 2. Morphological observation and cell viability of dermal papilla cells cultured on conventional 2D culture
plates and on human placenta extracellular matrix hydrogels. (A) Dermal papilla cells proliferate in an adherent
fashion with spindle-like morphology on conventional 2D plates. (B) Dermal papilla cells showed spherical
morphology on human placenta extracellular matrix hydrogels. (C) Live/dead staining showed that the cells were
alive when cultured on human placenta extracellular matrix hydrogel. Scale bars = 200 μm.
(Figure 4B) or the 2D-P8-DPCs group (Figure 4C). A few de novo HFs and pigmented hair shafts were visible in
the HPECM hydrogel-P8-DP sphere group (Figure 4D); H&E staining images further revealed the structure of
HFs induced by HPECM hydrogel-P8-DP spheres and epidermal cells (Figure 4E). Quantification of the number
of HF per graft site of the different groups is shown in Figure 4F.
Discussion
Although HF regeneration through tissue engineering has shown promise for the treatment of hair loss, many
unresolved questions remain and technical limitations need to be overcome before widespread clinical application
can be expected [24,25]. The HF is composed of epidermal (epithelial) and dermal (mesenchymal) compartments
and the interaction between these two parts is essential for HF regeneration [26]. The epidermal components include
HF stem cells, hair germinal matrix cells and the inner and outer root sheath, while the dermal components mainly
contain DP (DPC) and connective tissue sheath [27]. In essence, DPCs are a cluster of specialized mesenchymal
cells surrounded by epithelial cells at the base of HFs, which persist as the DP [11]. When HF formation first
occurs during embryogenesis, the epithelial part requires the guidance of DPCs to organize into the complex hair
structure [10,28]. In other words, the DPC is capable of induction of new HFs, the regulation of morphogenesis
and the control of the hair growth cycle. Because of their inherent inductive capacity, DPCs are considered to be
the optimal seeding cells source for HF reconstruction [29]. However, while cultured DPCs at early passages retain
their intrinsic property of inducing HF formation, those at high passages inevitably lose their inductive capacity,
leading to failure of HF formation [10,30].
Studies suggested that the hair-inducing ability of DPCs is closely related to their aggregative growth pattern.
There are several 3D culture systems which aim to maintain the DPCs’ inductive capacity through DP spheroid
formation [31]. The existing 3D culture systems include low binding plates or plates with synthetic membranes [32,33],
hanging drop methodology [34], the layer-by-layer (LbL) nanoencapsulation technique [35] and artificial scaffolds
such as collagen, gelatin-sponge or Matrigel R
[17]. Due to the low cell adhesion, ultra-low attachment substrates can
facilitate self-assembly of DPCs into 3D spheroids. However, the size of DP spheroids formed by low-binding plates
is often too large, which may easily lead to cell necrosis. The hanging drop is a simple method for forming spheroids
through surface tension of the droplet and the microgravity environment in each drop, but external forces such
2D – P2 HPECM – P8 2D – P8
2D – P2
HPECM – P8
2D – P8
****
Versican
1.5 NS ****
**** ****
Relative expression
NS **** NS ****
1.0
β-catenin
0.5
0.0 ALP
Versican β-catenin ALP
****
0.6 2D – P2
ALP
0.2
GAPDH
0.0
Versican β-catenin ALP
2D – P2
HPECM – P8
2D – P8
Figure 3. Signature gene and protein expression of dermal papilla cells cultured in 2D conditions and in human
placenta extracellular matrix hydrogel. (A) Gene expression of dermal papilla cells (DPCs) related to hair-inductive
capacity – ALP, β-catenin and Versican – was well maintained in the human placenta extracellular matrix (HPECM)
hydrogel-P8 group. (B) Similar to the qRT-PCR result, HPECM hydrogel-P8 DP spheres exhibited greater protein
expression compared with 2D-P8-DPCs. (C) The result of immunoblotting was in accordance with the results of
qRT-PCR and immunofluorescence. Expression levels of each marker were normalized to the internal control of
GAPDH.
****p < 0.05 compared with the 2D-P8-DPCs group. n = 3.
2D – P2: Passage 2 DPCs cultured on tissue culture plate; 2D – P8: Passage 8 DPCs cultured on tissue culture plate;
HPECM hydrogel-P8: Passage 8 DP spheres formed on HPECM hydrogel.
as collision or shaking will make these liquid drops more vulnerable to fall or spread out. LbL nanoencapsulation
is performed by employing gelatin and alginate for ultrathin nanocoated matrices on a single DPC, then DPCs
tend to form DP spheroids through electrostatic interactions between them, but the gelatin and alginate annex
additives to DPCs, which may affect the DPC’s functionality through some unknown cytokines. Matrigel R
, the
most commonly used scaffold, consists of proteins and ECM molecules extracted from basement membrane of a
mouse sarcoma, and thus cannot accurately represent the native ECM microenvironment in somatic tissues, while
the risk of tumor formation should also be taken into consideration [36]. More importantly, besides their respective
problems and limits, none of the above-mentioned methods truly represent the DPC niche in vivo [37,38].
A suitable microenvironment incorporating various physiological and chemical functions plays an indispensable
role in functional cell activity. It has been recognized for decades that the ECM is critical for cell proliferation,
Mouse epidermal cells Mouse epidermal cells Mouse epidermal cells Mouse epidermal cells
+ dermal cells + 2D-P8 DPCs + HPECM-P8 DP microtissues
150
follicles per graft
Number of hair
**
100
50
0
Positive
control
Negative
control
Experimental
group 1
Experimental
group 2
Figure 4. In vivo hair follicle regeneration assay. The subcutaneously implanted grafts were observed 2 weeks later.
(A) Positive control: neonatal mouse epidermal cells and dermal cells were co-transplanted. Many hairs were observed
in the recipient site of nude mice. (B) Negative control: neonatal mouse epidermal cells were transplanted alone, and
no hair induction was observed. (C) Experimental group 1: passage 8 DPCs grown on tissue culture plates were
co-transplanted with neonatal mouse epidermal cells, and no hairs were evident; (D) experimental group 2: passage 8
DP spheres cultured on HPECM hydrogel surface were co-transplanted with neonatal mouse epidermal cells.
Formation of several hairs could be seen at the recipient site. (E) H&E staining images showing HFs induced from
HPECM hydrogel-P8 DP spheres (scale bars = 200 μm). (F) Number of hair follicles formed per graft.
**p < 0.05 compared with the experimental group 1.
DPC: Dermal papilla cell; H&E: Hematoxylin and eosin; HF: Hair follicle; HPECM: Human placenta extracellular matrix.
morphogenesis and differentiation [12,39]. The ECM interacts with cells through its structural features and other
cues such as its bound growth factors and intracellular signaling, each of which result in cell fate decisions [40].
Thus, for the purpose of HF reconstruction, it is crucial to maintain the hair-inducing property of DPCs by
providing them with an instructive microenvironment comparable to that in vivo. Recent efforts have focused on
decellularization techniques to obtain DECM for use as a biologic scaffold which is similar to the original ECM
environment [41,42]. DECM scaffolds can be harvested from almost every tissue and organ. Several studies have
evaluated the effect of decellularized human placenta in therapeutic applications [43].
According to Choi et al., decellularized placental ECM sheets can be designed as a dermal substitute to support
the regeneration of full-thickness wounds with newly-formed HFs and microvessels [20]. Francis et al. reported that
human placenta-derived hydrogel reduced scarring in a rat model of cardiac ischemia and enhanced cardiomyocyte
and stem cell cultures [19]. Other studies have used human placenta extract as a cell culture supplement to promote
the hair-inductive capacity of DPCs by increasing β-catenin and Wnt3a expression levels [44,45]. Thus, we believe
HPECM hydrogel harvested from human placenta through decellularization techniques is suitable for HF tissue
engineering.
The decellularization methods implemented in this study effectively removed the cellular components, while
retaining bioactive molecules within the HPECM hydrogel after decellularization. Among these preserved bioactive
factors, FGF and PDGF are known to play crucial roles in promoting the hair-inducing ability of DPCs [46,47].
Pepsin-digested HPECM solution can self-assemble into hydrogel when brought to physiological conditions.
Formation of the HPECM hydrogel is a temperature- and/or pH-controlled collagen-based self-assembly process
without additional crosslinking agent that is initiated by the spontaneous reformation of the ECM protein monomer.
In an in vitro study, we demonstrated that the HPECM hydrogel can promote sphere formation of DPCs and
maintain their viability. In order to test the effect of HPECM hydrogels on the expression of hair-inducing-related
genes and proteins in DPCs, ALP [48], β-catenin [49] and Versican [50] were chosen as molecular markers, as they
are closely related to the hair-inducing ability of DPCs [32]. The qRT-PCR, immunostaining, and immunoblotting
results all verified that spheres formed on HPECM hydrogels did maintain expression of these marker genes and
proteins, which is in accordance with previous studies showing that sphere formation can restore the expression of
high-passage DPC markers [30]. In our in vivo study, we showed that mature follicles could be induced by DPCs
cultured on HPECM hydrogels and freshly isolated neonatal epidermal cells. Taken together, our results supported
the hypothesis that the microenvironment provided by HPECM hydrogel can restore the hair-inducing properties
of high-passage DPCs. The sphere formation and the presence of growth factors might account for this effect.
In previous studies, various forms of DECM derived from different tissues and organs have been used as biological
scaffolds for the engineering of functional tissues and organs including cartilage [51], bone [52], bladder [53], heart [54]
and liver [55]. In our study, we chose human placenta as the source. Compared with other source materials, this
HPECM hydrogel enjoys considerable advantages including: human placenta is an abundantly available donated
human organ, which is easy to obtain. The gelation process of HPECM hydrogel is simple, solubilized HPECM
remains liquid at room temperature and shows no gelation activity until the temperature of the material reaches
37◦ C, and no special tools or equipment are required. The HPECM hydrogel is suitable for long-term culture.
The HPECM hydrogel is rich in stemness factors, which can promote the maintenance of the inductive ability of
DPCs.
Another advantage of the HPECM hydrogel is its clinical applicability. Solubilized HPECM remains liquid at
room temperature and shows no gelation activity until the temperature reaches 37◦ C. Consequently, the gelation
property of the HPECM hydrogel greatly facilitates its practicality, especially for injectable delivery via minimally
invasive methods. Further investigations are needed to explore the potential of HPECM hydrogel via catheter
injection to provide a suitable microenvironment for HF regeneration, which may serve as the foundation for the
convenience of clinical application.
However, there is one limitation of our study, in that we did not assess the efficiency of HPECM hydrogel
in maintaining DPCs’ HF inductive capability compared with other 3D culture methods. Together, our research
team has reported on several methods, such as Matrigel R
culture [17], the hanging drop method [34] and the LbL
nanoencapsulation technique [35], mentioned above. We are dedicated to an in-depth comparative investigation
between different current methods to assess which method is more suitable for HF regeneration in future studies.
Conclusion
In summary, we used HPECM hydrogel as a bioactive scaffold which successfully restored the hair-inducing
properties of DPCs both in vivo and in vitro. Experimental results indicated that HPECM hydrogel is likely
to provide a favorable biomimetic microenvironment to regulate the morphology and function of DPCs by
reactivating key genes whose expression was lost under 2D conditions. We will conduct further research into the
exact mechanism of interactions between the environment and gene expression.
Future perspective
Recently, use of DECM scaffolds in tissue engineering and regenerative medicine has gained much interest. It
is important that such a scaffold should provide both mechanical support and abundant nutrients for the cells.
Human placenta contains plenty of ECM components and endogenous growth factors which are well preserved
after decellularization treatment. Thus, HPECM hydrogel derived from human placenta is an original, complex,
human, xeno-free, tumor-material-free ECM hydrogel, which mimics more characteristics of the extracellular
microenvironment in vivo than other 3D-culture systems. We demonstrated that HPECM hydrogel successfully
restored hair inductive capability of high-passaged DPCs, and thus could become a new option for HF tissue
engineering. In addition, considering its gelation property and lower immunogenicity, more research should be
done to explore the feasibility of using HPECM hydrogel for injectable delivery via minimally invasive methods,
which may be clinically helpful in future.
Summary points
• Decellularized extracellular matrix hydrogels from human placenta (human placenta extracellular matrix
[HPECM]) has the following advantages: easy to obtain; the gelation process is simple, allowing for long-term
cultivation, and it is rich in stemness factors.
• HPECM hydrogel establishes an instructive 3D environment, including mechanical stimulation and bioactive
molecules, for dermal papilla cells (DPCs) cultured on it.
• We explored the potential of HPECM hydrogel in restoring the hair-inductive capacity of high-passaged DPCs for
hair follicle regeneration both in vivo and in vitro.
• DPCs formed spheres when cultured on the HPECM hydrogel. The gene and protein expressions of Versican, ALP
and β-catenin, which are closely related to the hair-inducing capacity of DPCs, were restored in the HPECM
hydrogel-cultured DPCs compared with the 2D-cultured DPCs.
• High-passaged DPCs (P8) cultured on HPECM hydrogels successfully regenerated new hair follicle in nude mice,
whereas the DPCs cultured in 2D conditions did not.
• HPECM is likely to provide a favorable biomimetic microenvironment to regulate the morphology and function of
DPCs by reactivating key genes whose expression was lost under 2D conditions.
References
1. Mulinari-Brenner F, Bergfeld WF. Hair loss: an overview. Dermatol. Nurs. 13(4), 269–272, 277–278 (2001).
2. Han SH, Byun JW, Lee WS et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective,
multicenter study. Ann. Dermatol. 24(3), 311–318 (2012).
3. Miteva M, Tosti A. Treatment options for alopecia: an update, looking to the future. Expert Opin. Pharmacother. 13(9), 1271–1281
(2012).
4. Barbareschi M. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years. G. Ital.
Dermatol. Venereol. 153(1), 102–106 (2018).
5. Fertig RM, Gamret AC, Darwin E, Gaudi S. Sexual side effects of 5-alpha-reductase inhibitors finasteride and dutasteride: a
comprehensive review. Dermatol. Online. J. 23(11), pii:13030/qt24k8q743 (2017).
6. Jimenez-Acosta F, Ponce-Rodriguez I. Follicular unit extraction for hair transplantation: an update. Actas Dermosifiliogr. 108(6),
532–537 (2017).
7. Stenn K, Parimoo S, Zheng Y, Barrows T, Boucher M, Washenik K. Bioengineering the hair follicle. Organogenesis 3(1), 6–13 (2007).
8. Marshall BT, Ingraham CA, Wu X, Washenik K. Future horizons in hair restoration. Facial Plast. Surg. Clin. North Am. 21(3), 521–528
(2013).
9. Shimomura Y, Christiano AM. Biology and genetics of hair. J. Annu. Rev. Genomics Hum. Genet. 11, 109–132 (2010).
10. Driskell RR, Clavel C, Rendl M, Watt FM. Hair follicle dermal papilla cells at a glance. J. Cell Sci. 124(Pt 8), 1179–1182 (2011).
11. Yang CC, Cotsarelis G. Review of hair follicle dermal cells. J. Dermatol. Sci. 57(1), 2–11 (2010).
12. Rozario T, Desimone DW. The extracellular matrix in development and morphogenesis: a dynamic view. Dev. Biol. 341(1), 126–140
(2010).
13. Lee J, Cuddihy MJ, Kotov NA. Three-dimensional cell culture matrices: state of the art. Tissue Eng. Part B Rev. 14(1), 61–86 (2008).
14. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 7(3), 211–224 (2006).
15. Driskell RR, Juneja VR, Connelly JT, Kretzschmar K, Tan DW, Watt FM. Clonal growth of dermal papilla cells in hydrogels reveals
intrinsic differences between Sox2-positive and -negative cells in vitro and in vivo. J. Invest. Dermatol. 132(4), 1084–1093 (2012).
16. Toyoshima KE, Asakawa K, Ishibashi N et al. Fully functional hair follicle regeneration through the rearrangement of stem cells and their
niches. Nat. Commun. 3, 784 (2012).
17. Miao Y, Sun YB, Liu BC, Jiang JD, Hu ZQ. Controllable production of transplantable adult human high-passage dermal papilla
spheroids using 3D matrigel culture. Tissue Eng. Part A 20(17–18), 2329–2338 (2014).
18. Kakabadze Z, Kakabadze A, Chakhunashvili D et al. Decellularized human placenta supports hepatic tissue and allows rescue in acute
liver failure. Hepatology 67(5), 1956–1969 (2018).
19. Francis MP, Breathwaite E, Bulysheva AA et al. Human placenta hydrogel reduces scarring in a rat model of cardiac ischemia and
enhances cardiomyocyte and stem cell cultures. Acta Biomater. 52, 92–104 (2017).
20. Choi JS, Kim JD, Yoon HS, Cho YW. Full-thickness skin wound healing using human placenta-derived extracellular matrix containing
bioactive molecules. Tissue Eng. Part A 19(3–4), 329–339 (2013).
21. Yoon SY, Yoon JS, Jo SJ et al. A role of placental growth factor in hair growth. J. Dermatol. Sci. 74(2), 125–134 (2014).
22. Magerl M, Kauser S, Paus R, Tobin DJ. Simple and rapid method to isolate and culture follicular papillae from human scalp hair
follicles. Exp. Dermatol. 11(4), 381–385 (2002).
23. Zheng Y, Du X, Wang W, Boucher M, Parimoo S, Stenn K. Organogenesis from dissociated cells: generation of mature cycling hair
follicles from skin-derived cells. J. Invest. Dermatol. 124(5), 867–876 (2005).
24. Miao Y, Sun YB, Sun XJ, Du BJ, Jiang JD, Hu ZQ. Promotional effect of platelet-rich plasma on hair follicle reconstitution in vivo.
Dermatol. Surg. 39(12), 1868–1876 (2013).
25. Higgins CA, Chen JC, Cerise JE, Jahoda CA, Christiano AM. Microenvironmental reprogramming by three-dimensional culture enables
dermal papilla cells to induce de novo human hair-follicle growth. Proc. Natl Acad. Sci. USA 110(49), 19679–19688 (2013).
26. Oliver RF, Jahoda CA. Dermal-epidermal interactions. Clin. Dermatol. 6(4), 74–82 (1988).
27. Sennett R, Rendl M. Mesenchymal–epithelial interactions during hair follicle morphogenesis and cycling. Semin. Cell Dev. Biol. 23(8),
917–927 (2012).
28. Shimomura Y, Christiano AM. Biology and genetics of hair. Annu. Rev. Genomics Hum. Genet. 11, 109–132 (2010).
29. Qiao J, Zawadzka A, Philips E et al. Hair follicle neogenesis induced by cultured human scalp dermal papilla cells. Regen. Med. 4(5),
667–676 (2009).
30. Jahoda CA, Horne KA, Oliver RF. Induction of hair growth by implantation of cultured dermal papilla cells. Nature 311(5986),
560–562 (1984).
31. Higgins CA, Richardson GD, Ferdinando D, Westgate GE, Jahoda CA. Modelling the hair follicle dermal papilla using spheroid cell
cultures. Exp. Dermatol. 19(6), 546–548 (2010).
32. Kang BM, Kwack MH, Kim MK, Kim JC, Sung YK. Sphere formation increases the ability of cultured human dermal papilla cells to
induce hair follicles from mouse epidermal cells in a reconstitution assay. J. Invest. Dermatol. 132(1), 237–239 (2012).
33. Huang YC, Chan CC, Lin WT et al. Scalable production of controllable dermal papilla spheroids on PVA surfaces and the effects of
spheroid size on hair follicle regeneration. Biomaterials 34(2), 442–451 (2013).
34. Lin B, Miao Y, Wang J et al. Surface tension guided hanging-drop: producing controllable 3D spheroid of high-passaged human dermal
papilla cells and forming inductive microtissues for hair-follicle regeneration. J. ACS Appl. Mater Interfaces 8(9), 5906–5916 (2016).
35. Wang J, Miao Y, Huang Y et al. Bottom-up nanoencapsulation from single cells to tunable and scalable cellular spheroids for hair follicle
regeneration. Adv. Healthc. Mater. 7(3), doi:10.1002/adhm.201700447 (2017).
36. Benton G, Arnaoutova I, George J, Kleinman HK, Koblinski J. Matrigel: from discovery and ECM mimicry to assays and models for
cancer research. Adv. Drug Deliv. Rev. 79–80, 3–18 (2014).
37. Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv. Drug Deliv. Rev. 97, 4–27 (2016).
38. Miao Y, Fan ZX, Lj D et al. Effects of extracellular matrix on the growth characteristics of human dermal papillae cells in vitro. J. Clin.
Exp. Dermatol. 41(7), 792–797 (2016).
39. Watt FM, Huck WT. Role of the extracellular matrix in regulating stem cell fate. Nat. Rev. Mol. Cell Biol. 14(8), 467–473 (2013).
40. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 5(1),
1–13 (2009).
41. Faulk DM, Wildemann JD, Badylak SF. Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular
matrix. J. Clin. Exp. Hepatol. 5(1), 69–80 (2015).
42. Hoshiba T, Kawazoe N, Chen G. Preparation of cell-derived decellularized matrices mimicking native ECM during the osteogenesis and
adipogenesis of mesenchymal stem cells. Methods Mol. Biol. 1577, 71–86 (2018).
43. Luo X, Kulig KM, Finkelstein EB et al. In vitro evaluation of decellularized ECM-derived surgical scaffold biomaterials. J. Biomed. Mater.
Res. B Appl. Biomater. 105(3), 585–593 (2017).
44. Kwon TR, Oh CT, Park HM, Han HJ, Ji HJ, Kim BJ. Potential synergistic effects of human placental extract and minoxidil on hair
growth-promoting activity in C57BL/6J mice. Clin. Exp. Dermatol. 40(6), 672–681 (2015).
45. Kwon TR, Oh CT, Choi EJ et al. Human placental extract exerts hair growth-promoting effects through the GSK-3beta signaling
pathway in human dermal papilla cells. Int. J. Mol. Med. 36(4), 1088–1096 (2015).
46. Kiso M, Hamazaki TS, Itoh M, Kikuchi S, Nakagawa H, Okochi H. Synergistic effect of PDGF and FGF2 for cell proliferation and hair
inductive activity in murine vibrissal dermal papilla in vitro. J. Dermatol. Sci. 79(2), 110–118 (2015).
47. Lin WH, Xiang LJ, Shi HX et al. Fibroblast growth factors stimulate hair growth through beta-catenin and Shh expression in C57BL/6
mice. Biomed. Res. Int. 2015, 730139 (2015).
48. Handjiski BK, Eichmuller S, Hofmann U, Czarnetzki BM, Paus R. Alkaline phosphatase activity and localization during the murine hair
cycle. Br. J. Dermatol. 131(3), 303–310 (1994).
49. Gemayel R, Chenette EJ. β-catenin signalling in dermal papilla cells leads to a hairy situation. FEBS J. 283(15), 2820–2822 (2016).
50. Yang Y, Li Y, Wang Y et al. Versican gene: regulation by the beta-catenin signaling pathway plays a significant role in dermal papilla cell
aggregative growth. J. Dermatol. Sci. 68(3), 157–163 (2012).
51. Kim YS, Majid M, Melchiorri AJ, Mikos AG. Applications of decellularized extracellular matrix in bone and cartilage tissue engineering.
Bioeng. Transl. Med. 4(1), 83–95 (2019).
52. Chen G, Lv Y. Decellularized bone matrix scaffold for bone regeneration. Methods Mol. Biol. 1577, 239–254 (2018).
53. Coutu DL, Mahfouz W, Loutochin O, Galipeau J, Corcos J. Tissue engineering of rat bladder using marrow-derived mesenchymal stem
cells and bladder acellular matrix. PLoS ONE 9(12), e111966 (2014).
54. Akhyari P, Oberle F, Hulsmann J et al. Characterization of the epicardial adipose tissue in decellularized human-scaled whole hearts:
implications for the whole-heart tissue engineering. Tissue Eng. Part A 24(7–8), 682–693 (2018).
55. Mazza G, Rombouts K, Rennie Hall A et al. Decellularized human liver as a natural 3D-scaffold for liver bioengineering and
transplantation. Sci. Rep. 5, 13079 (2015).